“Interview with Dr. Huang Huiyao, Cancer Hospital of China Academy of Medical Sciences (CHCAMS)”
To many industry veterans, clinical development in China carries negative connotation. Among other things, quality has and continues to be
Tag: #China
The long-awaited roll out of the enhanced drug Marketing Authorization Holder (MAH) program in China
As a part of the drug evaluation and approval reform in China, the enhanced Marketing Authorization Holder (MAH) system is
New Accelerated Regulatory Paths in China
At the end of August, China’s legislature finally approved the long-awaited Drug Administration Law. Capping the dizzying regulatory reform since
CHINA’S IMPORT TARIFF EXEMPTION AND ITS IMPACTS
India is one of the leaders and has the largest manufacturers of generic drugs globally with a recorded export value